Daniella Mehalik
Financieel Directeur/CFO bij PSYCHEMEDICS CORPORATION
Profiel
Daniella Mehalik is currently the Vice President-Finance & Treasurer at Psychemedics Corp.
Prior to this, she worked as a Controller at NeuBase Therapeutics, Inc. from 2021 to 2023 and at DxTx Medical, Inc. from 2019 to 2021.
She holds undergraduate and graduate degrees from Carlow University Of.
Actieve functies van Daniella Mehalik
| Bedrijven | Functie | Begin |
|---|---|---|
| PSYCHEMEDICS CORPORATION | Financieel Directeur/CFO | 27-11-2023 |
Eerdere bekende functies van Daniella Mehalik
| Bedrijven | Functie | Einde |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-01-2023 |
| DxTx Medical, Inc. | Comptroller/Controller/Auditor | 01-01-2021 |
Opleiding van Daniella Mehalik
| Carlow University Of | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PSYCHEMEDICS CORPORATION | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
| DxTx Medical, Inc. |
